Floatz logo

Tilmanocept

Vascular Calcification

Massachusetts General HospitalOtherActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Vascular Calcification cohort.

Asset / SponsorPhaseRating
THROCALCITONIN
National Center for Research Resources (NCRR)
Phase 2B
Copper Cu-64-Dota-Alendronate
City of Hope Medical Center
Early Phase 1CC
Inomax
RoseLab Skin Optics Laboratory
NR

Same molecule, other indications

Tilmanocept is also rated in:

melanomaDormant
B
Indicative ·
61 / 100
View asset →
Sentinel Lymph Node BiopsyDormant
B
Indicative ·
56 / 100
View asset →
Sentinel Lymph NodeDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →